News & Articles

FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Biosystems, INTEGRA Biosciences and Sartorius among those recognized

UN3373 compliant sample packaging solution

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling

Discover how to increase precision and reduce throughput time of your routine electrolyte analyses

Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery

The findings could lead to faster, more secure memory storage, in the form of antiferromagnetic bits

Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time

Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies

Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations

Ongoing recruitment strengthens teams in all areas of integrated discovery